Year All2024202320222021202020192018201720162015201420132012201120102007 02.08.12 Syndax Pharmaceuticals Announces Entinostat Enhanced Activity of Cancer Immunotherapies in Renal and Prostate Cancer Models Read More 02.07.12 Syndax Pharmaceuticals to Present at Upcoming Conferences Read More 01.05.12 Syndax Pharmaceuticals Signs Agreement with Ventana Medical Systems, Inc. to Develop Companion Diagnostic Test for Entinostat Read More 12.20.11 ENGAGE 501 Poster Presented by Dr. Anas Younes at ASH 2011 Read More 12.11.11 Entinostat Demonstrates Activity in Hodgkin's Lymphoma Read More 12.07.11 Survival Benefit With Syndax Pharmaceuticals' Entinostat Maintained in Women with Advanced Breast Cancer Read More 12.07.11 ENCORE 301 Poster Presented by Dr. Denise Yardley at SABCS Read More 12.01.11 Multiple Data Presentations on Syndax Pharmaceutical's Entinostat at Upcoming Scientific Conferences Read More 11.13.11 Syndax Pharmaceuticals Presents Data Linking Pharmacodynamic Marker to Clinical Benefit in Advanced Breast Cancer Patients Read More 11.05.11 Bio-Technology Corporations, Banking Institutions and MGH Support the Breathe Deep Boston 5K Walk 2011 in this Difficult Economy Read More 11.02.11 Pharmacodynamic Data from Syndax Pharmaceutical's ENCORE 301 Study in Advanced Breast Cancer to be Highlighted at the AACR Molecular Targets and Cancer Therapeutics Conference 2011 Read More 10.24.11 Syndax Pharmaceuticals to Present at Upcoming Fall Conferences Read More
02.08.12 Syndax Pharmaceuticals Announces Entinostat Enhanced Activity of Cancer Immunotherapies in Renal and Prostate Cancer Models Read More
01.05.12 Syndax Pharmaceuticals Signs Agreement with Ventana Medical Systems, Inc. to Develop Companion Diagnostic Test for Entinostat Read More
12.07.11 Survival Benefit With Syndax Pharmaceuticals' Entinostat Maintained in Women with Advanced Breast Cancer Read More
12.01.11 Multiple Data Presentations on Syndax Pharmaceutical's Entinostat at Upcoming Scientific Conferences Read More
11.13.11 Syndax Pharmaceuticals Presents Data Linking Pharmacodynamic Marker to Clinical Benefit in Advanced Breast Cancer Patients Read More
11.05.11 Bio-Technology Corporations, Banking Institutions and MGH Support the Breathe Deep Boston 5K Walk 2011 in this Difficult Economy Read More
11.02.11 Pharmacodynamic Data from Syndax Pharmaceutical's ENCORE 301 Study in Advanced Breast Cancer to be Highlighted at the AACR Molecular Targets and Cancer Therapeutics Conference 2011 Read More